All News Top News Aug 16, 2018 Teva and Regeneron Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip Learn More Share Top News Aug 6, 2018 Teva Announces Updated Indication and Vial Presentation for GRANIX® (tbo-filgrastim) Injection in United States Learn More Share Top News Aug 2, 2018 Teva Reports Second Quarter 2018 Financial Results Learn More Share Top News Jul 17, 2018 Teva Highlights Key Milestones Achieved in the 2017 Social Impact Report Learn More Share Top News Jul 11, 2018 Teva to Report Second Quarter 2018 Financial Results on August 2, 2018 Learn More Share
Top News Aug 16, 2018 Teva and Regeneron Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip Learn More
Top News Aug 6, 2018 Teva Announces Updated Indication and Vial Presentation for GRANIX® (tbo-filgrastim) Injection in United States Learn More
Top News Jul 17, 2018 Teva Highlights Key Milestones Achieved in the 2017 Social Impact Report Learn More
Top News Jul 11, 2018 Teva to Report Second Quarter 2018 Financial Results on August 2, 2018 Learn More